Clinical Trial

Clinical Study to Evaluate the Safety, Pharmacokinetics and Efficacy of VC005 in Adolescent Subjects With Mild to Moderate Atopic Dermatitis

Completed Phase 1
View on ClinicalTrials.gov →
Summary
This is a single arm, and open-label phase I study
Protocol Amendment History 4 changes
critical Trial completed 2026-04-14
notable Enrollment increased: 10 -> 11 participants 2026-04-14
notable Primary completion moved earlier: 2026-06-30 -> 2026-02-06 2026-04-14
minor Completion moved earlier: 2026-06-30 -> 2026-02-28 2026-04-14
Trial Details
NCT Number NCT07329101
Lead Sponsor Jiangsu vcare pharmaceutical technology co., LTD
Conditions Atopic Dermatitis (AD)
Enrollment 11 participants
Start Date 2025-11-11
Primary Completion 2026-02-06 (estimated)
Study Completion 2026-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-04-13